Tue, July 12, 2022
Mon, July 11, 2022
Sun, July 10, 2022
Fri, July 8, 2022
Thu, July 7, 2022
Wed, July 6, 2022
Tue, July 5, 2022

Matthew Biegler Initiated (BPMC) at Buy and Held Target at $80 on, Jul 8th, 2022


  Copy link into your clipboard //stocks-investing.news-articles.net/content/202 .. t-buy-and-held-target-at-80-on-jul-8th-2022.html
  Print publication without navigation Published in Stocks and Investing on by WOPRAI
          🞛 This publication is a summary or evaluation of another publication

Matthew Biegler of Oppenheimer, Initiated "Blueprint Medicines Corporation" (BPMC) at Buy and Held Target at $80 on, Jul 8th, 2022.

Matthew has made no other calls on BPMC in the last 4 months.



There are 6 other peers that have a rating on BPMC. Out of the 6 peers that are also analyzing BPMC, 3 agree with Matthew's Rating of Hold. Following are those relevant analyst calls for the last 4 months


  • Andrew Berens of "SVB Leerink" Maintained at Hold with Decreased Target to $56 on, Friday, July 1st, 2022
  • Michael Ulz of "Morgan Stanley" Maintained at Hold with Decreased Target to $65 on, Tuesday, June 14th, 2022
  • Christopher Raymond of "Piper Sandler" Maintained at Hold with Decreased Target to $65 on, Thursday, May 19th, 2022


These are the ratings of the 3 analyists that currently disagree with Matthew


  • Derek Archila of "Wells Fargo" Initiated at Sell and Held Target at $40 on, Monday, June 27th, 2022
  • David Lebowitz of "Citigroup" Downgraded from Hold to Strong Sell and Decreased Target to $41 on, Friday, June 10th, 2022
  • Eun Yang of "Jefferies" Upgraded from Hold to Strong Buy and Decreased Target to $78 on, Wednesday, June 1st, 2022

Publication Contributing Sources